CLDN8 and inflammatory bowel disease: (2016) identified the cross-talk mechanism between the IL-23 pathway and the intestinal epithelial barrier in IBD and showed that miR-223 was a crucial pro-inflammatory component of the IL-23 pathway in IBD patients and animals, and negatively modulated its targets, including claudin-8 (1).